METTL1


Description

The METTL1 (methyltransferase 1, tRNA methylguanosine) is a protein-coding gene located on chromosome 12.

METTL1 is a human gene encoding tRNA (guanine-N(7)-)-methyltransferase, an enzyme involved in RNA methylation. The gene shares sequence similarity with the S. cerevisiae YDL201w gene and contains a conserved S-adenosylmethionine-binding motif. It is inactivated by phosphorylation and produces various protein isoforms through alternative splicing. Different transcript variants utilizing alternative polyA sites have also been reported.

METTL1 is a catalytic component of the METTL1-WDR4 methyltransferase complex. This complex mediates the formation of N(7)-methylguanine in a subset of RNA species, including tRNAs, mRNAs, and microRNAs (miRNAs). Specifically, METTL1 catalyzes the formation of N(7)-methylguanine at position 46 (m7G46) in a large subset of tRNAs that contain the 5'-RAGGU-3' motif within the variable loop. This modification stabilizes tRNA tertiary structure by interacting with C13-G22 in the D-loop and protects tRNAs from decay. METTL1 also acts as a methyltransferase for a subset of internal N(7)-methylguanine in mRNAs, promoting their relocalization to stress granules under stress conditions, thereby suppressing their translation. Additionally, METTL1 methylates a specific subset of miRNAs, such as let-7, promoting let-7 miRNA processing by disrupting an inhibitory secondary structure within the primary miRNA transcript (pri-miRNA). METTL1 is also implicated in the regulation of embryonic stem cell self-renewal and differentiation.

METTL1 is also known as C12orf1, TRM8, TRMT8, YDL201w.

Associated Diseases



Disclaimer

The information provided here is not exhaustive by any means. Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.